• Submitted by: Luis Manuel Mazorra
• Health and Medicine
• 02 / 29 / 2012

---

 

The drug Heberprot-P, a result of the achievements of Cuban biotechnology has been used in nearly five years of its approval, in about nine thousand patients suffering from Diabetes, expanding their use at primary health level.

The Cuban medicine is unique in the world, is used in the treatment of foot ulcers in people with diabetes, and prevent amputation of the lower limb in most cases.

The lawyer Israel Miranda, a specialist of the national group responsible for product expansion, told AIN that Sancti Spiritus is the province that stands out most in your application, followed by Ciego de Avila and Villa Clara.

Prepared jointly by the Center for Genetic Engineering and Biotechnology (ICGEB) in Havana and the National Institute of Angiology and Vascular Surgery, Heberprot-P has proven highly effective in healing diabetic foot ulcers called, experts say.

The degree Yudelka Rivero, developer of the Ministry of Public Health, said that may extend into the community and the proof is in the territory Spiritus eight of its 23 clinics still do not practice this therapeutic procedure.

According to records, the country has about 40 thousand people there in need of treatment and availability of the drug to cope with the demand.

It will also be offered to other nations, the proof is in trade agreements and ongoing negotiations with institutions in over 50 countries, including Canada, China, Russia, the European Union, Brazil and Venezuela.

Have shown interest in the product states in the U.S., a country where annual report more than 85 000 amputations due to diabetic foot ulcers.

Public health statistics that account for more than three percent of the Cuban population have diabetes mellitus, a disease that is the main reason for admission in angiology services of countries like the U.S., Britain, Spain, Mexico and Brazil.